Luni Emdad Selected Research

Syndecans

1/2021	Pharmacological inhibition of MDA-9/Syntenin blocks breast cancer metastasis through suppression of IL-1β.
1/2020	MDA-9/Syntenin (SDCBP): Novel gene and therapeutic target for cancer metastasis.
1/2020	MDA-9/Syntenin/SDCBP: new insights into a unique multifunctional scaffold protein.
1/2019	MDA-9/Syntenin: An emerging global molecular target regulating cancer invasion and metastasis.
1/2018	The MDA-9/Syntenin/IGF1R/STAT3 Axis Directs Prostate Cancer Invasion.
1/2018	MDA-9/Syntenin regulates protective autophagy in anoikis-resistant glioma stem cells.
10/2017	Inhibition of radiation-induced glioblastoma invasion by genetic and pharmacological targeting of MDA-9/Syntenin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Luni Emdad Research Topics

Disease

94	Neoplasms (Cancer) 03/2022 - 01/2005
56	Melanoma (Melanoma, Malignant) 01/2022 - 06/2005
25	Neoplasm Metastasis (Metastasis) 12/2021 - 12/2005
23	Glioma (Gliomas) 01/2018 - 06/2005
11	Glioblastoma (Glioblastoma Multiforme) 03/2020 - 06/2008
10	Breast Neoplasms (Breast Cancer) 01/2021 - 06/2005
9	Infections 01/2016 - 10/2004
7	Hepatocellular Carcinoma (Hepatoma) 02/2015 - 05/2010
6	Carcinogenesis 01/2020 - 11/2006
6	Pancreatic Neoplasms (Pancreatic Cancer) 03/2016 - 01/2014
5	Prostatic Neoplasms (Prostate Cancer) 12/2019 - 05/2015
5	Inflammation (Inflammations) 01/2018 - 10/2004
4	Neuroblastoma 11/2021 - 01/2016
4	Brain Neoplasms (Brain Tumor) 10/2017 - 01/2010
3	Colorectal Neoplasms (Colorectal Cancer) 02/2021 - 11/2007
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 05/2008
2	Hypoxia (Hypoxemia) 03/2020 - 12/2009
2	Leukemia 03/2020 - 01/2020
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2008 - 02/2007
1	Experimental Melanoma 01/2022
1	Liver Neoplasms (Liver Cancer) 01/2020
1	Carcinoma (Carcinomatosis) 01/2019
1	Neurocognitive Disorders (Clerambault Syndrome) 01/2017
1	Central Nervous System Diseases (CNS Diseases) 01/2017

Drug/Important Bio-Agent (IBA)

34	Proteins (Proteins, Gene)FDA Link 12/2021 - 11/2005
25	CytokinesIBA 01/2022 - 10/2004
24	InterleukinsIBA 12/2021 - 10/2004
24	SynteninsIBA 01/2021 - 12/2005
8	Pharmaceutical PreparationsIBA 11/2019 - 11/2007
7	Interleukin-10 (Interleukin 10)IBA 12/2021 - 08/2006
7	Carrier Proteins (Binding Protein)IBA 01/2021 - 10/2017
7	SyndecansIBA 01/2021 - 10/2017
6	CaspasesIBA 01/2016 - 02/2008
5	Transcription Factors (Transcription Factor)IBA 03/2022 - 01/2005
5	Biological ProductsIBA 12/2021 - 12/2005
5	Small Interfering RNA (siRNA)IBA 01/2014 - 05/2007
5	NF-kappa B (NF-kB)IBA 03/2008 - 10/2004
4	MicroRNAs (MicroRNA)IBA 01/2019 - 03/2015
4	Interleukin-6 (Interleukin 6)IBA 01/2018 - 10/2004
4	Caspase 3 (Caspase-3)IBA 01/2017 - 06/2008
4	Messenger RNA (mRNA)IBA 02/2015 - 08/2005
3	CateninsIBA 02/2021 - 01/2017
3	mezereinIBA 11/2020 - 09/2006
3	Interferon-betaIBA 11/2020 - 09/2006
3	Temozolomide (Temodar)FDA LinkGeneric 03/2020 - 04/2014
3	ErbB Receptors (EGF Receptor)IBA 01/2020 - 02/2007
3	Tamoxifen FDA LinkGeneric 01/2018 - 01/2013
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017 - 11/2010
3	AgarIBA 03/2015 - 06/2005
3	p38 Mitogen-Activated Protein KinasesIBA 01/2014 - 08/2006
3	Glutamic Acid (Glutamate)FDA Link 10/2011 - 06/2005
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 11/2006
2	interleukin-24 (ST16)IBA 01/2022 - 01/2018
2	VinculinIBA 02/2021 - 01/2019
2	Cadherins (E-Cadherin)IBA 02/2021 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2015
2	Beclin-1IBA 01/2018 - 01/2017
2	AD 5IBA 01/2018 - 01/2016
2	Interleukin-8 (Interleukin 8)IBA 01/2018 - 10/2004
2	Recombinant ProteinsIBA 01/2018 - 06/2008
2	Complement System Proteins (Complement)IBA 01/2017 - 01/2015
2	Doxycycline (Periostat)FDA LinkGeneric 11/2015 - 12/2014
2	CholesterolIBA 07/2015 - 01/2013
2	1,1',6,6',7,7'- hexahydroxy- 3,3'- dimethyl- N5- (2- phenylpropyl)- N5'- (2- phenylpropyl)- 2,2'- binaphthyl- 5,5'- dicarboxamideIBA 06/2015 - 11/2012
2	Micrococcal NucleaseIBA 02/2015 - 01/2014
2	Matrix Metalloproteinases (MMPs)IBA 01/2015 - 10/2004
2	Interferon Type IIBA 03/2014 - 11/2007
2	Polyribonucleotide Nucleotidyltransferase (Polynucleotide Phosphorylase)IBA 01/2013 - 10/2004
2	CeramidesIBA 11/2010 - 05/2009
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 12/2009 - 11/2006
2	matrigelIBA 12/2009 - 02/2006
2	Monoclonal AntibodiesIBA 03/2009 - 11/2007
2	Amino Acids FDA Link 06/2008 - 08/2006
2	NF-KappaB Inhibitor alphaIBA 02/2007 - 10/2004
1	GATA2 Transcription FactorIBA 03/2022
1	ConnexinsIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Riboflavin (Vitamin B2)FDA LinkGeneric 01/2022
1	Intercalating AgentsIBA 01/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2021
1	Cisplatin (Platino)FDA LinkGeneric 12/2021
1	InterferonsIBA 12/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Glutamine (L-Glutamine)FDA Link 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Antimalarials (Antimalarial Agents)IBA 01/2020
1	Lumefantrine FDA Link 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Calcibiotic Root Canal SealerIBA 01/2019
1	3- (3- (1H- benzo(d)imidazol- 2- yl)acryloyl)- 6- chloro- 4- phenylquinolin- 2(1H)- oneIBA 01/2019
1	SolutionsIBA 01/2018
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2018
1	GoldIBA 01/2018

Therapy/Procedure

57	Therapeutics 01/2022 - 01/2005
12	Drug Therapy (Chemotherapy) 01/2021 - 08/2006
6	Radiotherapy 10/2017 - 08/2006
2	Injections 12/2021 - 09/2006
2	Precision Medicine 02/2021 - 01/2018
2	Immunotherapy 01/2018 - 03/2016
2	Microbubbles 01/2018 - 05/2015